Back to search

Mucora Therapeutics Ltd

13169210

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

LABURNUM HOUSE, SALISBURY, SP5 3RT
Incorporated 01/02/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Mark Edward Brimble

director · Since 01/02/2021

DIRECTOR

BRITISH · UNITED KINGDOM · Age 56

Also on 1 other board

Ms Joanne Collett

director · Since 01/02/2021

DIRECTOR

BRITISH · UNITED KINGDOM · Age 59

Mr David Martyn Fleet

director · Since 01/02/2021

DIRECTOR

BRITISH · UNITED KINGDOM · Age 68

Also on 4 other boards

Mr Joshua Fleet

director · Since 01/02/2021

DIRECTOR

BRITISH · UNITED KINGDOM · Age 38

Persons with Significant Control

Mr David Martyn Fleet

Significant control

British · United Kingdom · Age 68

Laburnum House, East Grimstead, Salisbury, SP5 3RT

Notified 01/02/2021

Mr Joshua Fleet

Significant control

British · United Kingdom · Age 38

Laburnum House, East Grimstead, Salisbury, SP5 3RT

Notified 01/02/2021

Mark Edward Brimble

Significant control

British · United Kingdom · Age 56

Laburnum House, East Grimstead, Salisbury, SP5 3RT

Notified 01/02/2021

Joanne Collett

Significant control

British · United Kingdom · Age 59

Laburnum House, East Grimstead, Salisbury, SP5 3RT

Notified 01/02/2021

CompanyRankvs 1561+ SIC 72110 peers
52

Financial strength93th percentile among SIC peers · 23/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio -10.69× · 2/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1561Mucora Therapeutics Ltd
50
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 28/02/2025

Net Worth

£1.2M

Balance sheet strength

Cash

£1.1M

Cash in the bank

Net Current Assets

£1.2M

Working capital

Current Assets

£1.1M

Current Liabilities

-£101k

Debtors

£84

1avg. employees

Balance Sheet

Assets less current liabilities£1.2M
Signed by Mr Joshua Fleet 01/09/2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202510.69-£320k
202424.08—
20230.82—

Derived from filed accounts. Not audited figures.